Cite
HARVARD Citation
Ayaz Ahmed, K. et al. (2016). Jacalin-capped silver nanoparticles minimize the dosage use of the anticancer drug, shikonin derivatives, against human chronic myeloid leukemia. RSC advances. 6 (23), pp. 18980-18989. [Online].